Peripapillary choroidal atrophy in sympathetic ophthalmia and management with triple-agent immunosuppression.
Ocul Immunol Inflamm
; 11(1): 61-5, 2003 Mar.
Article
en En
| MEDLINE
| ID: mdl-12854028
ABSTRACT
PURPOSE:
To describe the occurrence of peripapillary choroidal atrophy and experience with triple-agent immunosuppression in three cases of sympathetic ophthalmia. MATERIALS ANDMETHODS:
Retrospective chart review of three cases of sympathetic ophthalmia with peripapillary choroidal atrophy.RESULTS:
Three patients with sympathetic ophthalmia were managed with steroid pulse therapy and triple-agent immunosuppression. All three patients subsequently developed peripapillary choroidal atrophy.CONCLUSIONS:
Peripapillary choroidal atrophy can occur in sympathetic ophthalmia and may indicate a severe form of inflammation which would benefit from triple-agent immunosuppression.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Enfermedades de la Coroides
/
Oftalmía Simpática
/
Coroides
/
Inmunosupresores
Tipo de estudio:
Observational_studies
/
Risk_factors_studies
Límite:
Adult
/
Child
/
Humans
/
Male
Idioma:
En
Revista:
Ocul Immunol Inflamm
Asunto de la revista:
ALERGIA E IMUNOLOGIA
/
OFTALMOLOGIA
Año:
2003
Tipo del documento:
Article
País de afiliación:
India